Literature DB >> 31160239

Early-life exposure to electronic cigarettes: cause for concern.

Alexander N Larcombe1.   

Abstract

Electronic nicotine delivery systems, or ENDS, are devices that heat and aerosolise a solution of propylene glycol, glycerine, nicotine, and flavourings. They have only achieved widespread use in the past 5 years or so, and therefore evidence around their potential to effect health is scarce. Importantly, they are often viewed as safer than tobacco cigarettes, meaning that at-risk populations, including pregnant women, might be more inclined to use them. No human studies, however, have assessed the potential for maternal ENDS use to effect the health of a developing baby. Experimental research suggests that nicotine alone is likely to adversely affect the fetus. Further, there is a misconception that ENDS do not produce second-hand aerosols. This misconception might put infants and young children at risk because their parents are more likely to use ENDS around them than they are to use tobacco cigarettes. Emerging evidence also proposes that nicotine and other substances produced by ENDS can deposit onto surfaces, and subsequently be exposed to infants and children; a process known as third-hand exposure. Finally, ENDS are often refillable, and instances of accidental poisonings of children who drink nicotine-containing refills have occurred. Thus, there are a multitude of ways that, with respect to early-life exposures and health, ENDS are a cause for concern.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31160239     DOI: 10.1016/S2213-2600(19)30189-4

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   30.700


  7 in total

1.  Supporting Parents Living in Disadvantaged Areas of Edinburgh to Create a Smoke-Free Home Using Nicotine Replacement Therapy (NRT): A Two-Phase Qualitative Study.

Authors:  Rachel O'Donnell; Grace Lewis; Colin Lumsdaine; Giovanna Di Tano; Liz Swanston; Gillian Amos; Anne Finnie; Neneh Rowa-Dewar
Journal:  Int J Environ Res Public Health       Date:  2020-10-07       Impact factor: 3.390

Review 2.  What are the respiratory effects of e-cigarettes?

Authors:  Jeffrey E Gotts; Sven-Eric Jordt; Rob McConnell; Robert Tarran
Journal:  BMJ       Date:  2019-09-30

3.  E-Cigarette Use among Current Smokers Experiencing Homelessness.

Authors:  Arturo Durazo; Marlena Hartman-Filson; Holly Elser; Natalie M Alizaga; Maya Vijayaraghavan
Journal:  Int J Environ Res Public Health       Date:  2021-04-01       Impact factor: 4.614

Review 4.  Pediatric Preventive Care in Middle-High Resource Countries-The Padova Chart for Health in Children.

Authors:  Alfonso Galderisi; Giorgio Perilongo; Sonia Caprio; Liviana Da Dalt; Giovanni Di Salvo; Michela Gatta; Carlo Giaquinto; Rosario Rizzuto; Adelaide Robb; Peter David Sly; Alessandra Simonelli; Annamaria Staiano; Roberto Vettor; Eugenio Baraldi
Journal:  Front Pediatr       Date:  2022-04-14       Impact factor: 3.418

5.  Association between Heated Tobacco Product Use during Pregnancy and Fetal Growth in Japan: A Nationwide Web-Based Survey.

Authors:  Yoshihiko Hosokawa; Masayoshi Zaitsu; Sumiyo Okawa; Naho Morisaki; Ai Hori; Yukiko Nishihama; Shoji F Nakayama; Takeo Fujiwara; Hiromi Hamada; Toyomi Satoh; Takahiro Tabuchi
Journal:  Int J Environ Res Public Health       Date:  2022-09-19       Impact factor: 4.614

6.  Fetal Origins of Asthma: A Longitudinal Study from Birth to Age 36 Years.

Authors:  Stefano Guerra; Enrico Lombardi; Debra A Stern; Duane L Sherrill; Dorothy Gilbertson-Dahdal; Courtney M Wheatley-Guy; Eric M Snyder; Anne L Wright; Fernando D Martinez; Wayne J Morgan
Journal:  Am J Respir Crit Care Med       Date:  2020-12-15       Impact factor: 21.405

7.  Prevalence and Distribution of Electronic Cigarette Use Before and During Pregnancy Among Women in 38 States of the United States.

Authors:  Buyun Liu; Yang Du; Yuxiao Wu; Yangbo Sun; Mark K Santillan; Donna A Santillan; Wei Bao
Journal:  Nicotine Tob Res       Date:  2021-08-18       Impact factor: 4.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.